Abstract: Detecting obstructive sleep apnea (OSA) is essential for diagnosing and managing sleep health. Traditionally, this involves clinical settings with hardly accessible processes. We propose ...
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference ...
Nyxoah today announced a significant reimbursement win through the U.S. Centers for Medicare & Medicaid Services (CMS).
8d
Daily oral GLP-1 pill a promising alternative to injectables for weight loss, clinical trial finds
A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar ...
“How Dental Sleep Medicine Expert Dr. Monica M. Pierpan of Hampstead Explains Sleep Apnea Treatment for HelloNation” features ...
Discover key insights from Vivos Therapeutics’ Q3 2025 earnings: strategic growth, 76% revenue surge, and future outlook in sleep disorder treatment.
Q3 2025 Earnings Call November 19, 2025 5:00 PM ESTCompany ParticipantsBradford Amman - CFO, Treasurer & SecretaryR.
The use of electrical stimulation of the upper airway to treat patients with obstructive sleep apnea (OSA) is supported by low-quality evidence.
Senate Democrats unveiled their alternative to Republicans' plan to reopen the government that would see an extension to expiring Obamacare credits for one year, asking that Republicans just say "yes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback